Tousignant C, Chrétien L, Guillemette G, Regoli D
Department of Pharmacology, School of Medicine, University of Sherbrooke, Que., Canada.
Brain Res. 1992 Nov 20;596(1-2):243-50. doi: 10.1016/0006-8993(92)91554-r.
The major finding of the present investigation is the demonstration of different NK-1 receptors in rat and guinea pig brain membranes with CP 96345 (non-peptide NK-1 antagonist) and R-544 (NK-1 peptide antagonist). We used [3H][Sar9,Met(O2)11]SP, the highly selective ligand for NK-1 receptor to compare NK-1 binding sites in rat and guinea pig brain membranes. Scatchard analysis revealed the existence of a single population of [3H][Sar9,Met(O2)11]SP binding sites in both preparations. The affinity and the maximal number of binding sites were found closely similar in rat (Kd 2 nM, Bmax = 37 fmol/mg protein) and guinea pig brain membranes (Kd = 3 nM, Bmax = 25 fmol/mg of protein). The order of potency of neurokinins to inhibit [3H][Sar9,Met(O2)11]SP binding from rat brain (SP > NKA > NKB) was found different of that observed on guinea pig brain (SP > NKB > NKA). Results obtained with [Sar9,Met(O2)11]SP, [beta Ala8]NKA(4-10) and [MePhe7]NKB suggest that selective agonists cannot discriminate between NK-1 receptors of different species. Using the non-peptide antagonist CP 96345 and the tripeptide R-544, we found that these two NK-1 antagonists discriminate between rat and guinea pig [3H][Sar9,Met(O2)11]SP binding sites.
本研究的主要发现是,利用CP 96345(非肽类NK-1拮抗剂)和R-544(NK-1肽拮抗剂)证明了大鼠和豚鼠脑膜中存在不同的NK-1受体。我们使用[3H][Sar9,Met(O2)11]SP(NK-1受体的高度选择性配体)来比较大鼠和豚鼠脑膜中的NK-1结合位点。Scatchard分析显示,两种制剂中均存在单一群体的[3H][Sar9,Met(O2)11]SP结合位点。发现大鼠(Kd = 2 nM,Bmax = 37 fmol/mg蛋白)和豚鼠脑膜(Kd = 3 nM,Bmax = 25 fmol/mg蛋白)中结合位点的亲和力和最大数量非常相似。发现神经激肽抑制大鼠脑[3H][Sar9,Met(O2)11]SP结合的效力顺序(SP > NKA > NKB)与在豚鼠脑上观察到的不同(SP > NKB > NKA)。用[Sar9,Met(O2)11]SP、[βAla8]NKA(4-10)和[MePhe7]NKB获得的结果表明,选择性激动剂无法区分不同物种的NK-1受体。使用非肽拮抗剂CP 96345和三肽R-544,我们发现这两种NK-1拮抗剂能够区分大鼠和豚鼠的[3H][Sar9,Met(O2)11]SP结合位点。